163 related articles for article (PubMed ID: 32903038)
1. Orally administered emu oil attenuates disease in a mouse model of Crohn's-like colitis.
Mitchell CJ; Howarth GS; Chartier LC; Trinder D; Lawrance IC; Huang LS; Mashtoub S
Exp Biol Med (Maywood); 2020 Dec; 245(18):1697-1707. PubMed ID: 32903038
[TBL] [Abstract][Full Text] [Related]
2. Intestinal homeostasis is restored in mice following a period of intestinal growth induced by orally administered Emu Oil.
Mashtoub S; Cheah KY; Lymn KA; Howarth GS
Exp Biol Med (Maywood); 2018 Jul; 243(11):945-952. PubMed ID: 29985049
[TBL] [Abstract][Full Text] [Related]
3. Emu Oil reduces disease severity in a mouse model of chronic ulcerative colitis.
Safaeian R; Howarth GS; Lawrance IC; Trinder D; Mashtoub S
Scand J Gastroenterol; 2019 Mar; 54(3):273-280. PubMed ID: 30907169
[No Abstract] [Full Text] [Related]
4. Emu oil increases colonic crypt depth in a rat model of ulcerative colitis.
Abimosleh SM; Lindsay RJ; Butler RN; Cummins AG; Howarth GS
Dig Dis Sci; 2012 Apr; 57(4):887-96. PubMed ID: 22147247
[TBL] [Abstract][Full Text] [Related]
5. Emu Oil Improves Clinical Indicators of Disease in a Mouse Model of Colitis-Associated Colorectal Cancer.
Chartier LC; Howarth GS; Lawrance IC; Trinder D; Barker SJ; Mashtoub S
Dig Dis Sci; 2018 Jan; 63(1):135-145. PubMed ID: 29214422
[TBL] [Abstract][Full Text] [Related]
6. Emu oil and grape seed extract reduce tumour burden and disease parameters in murine colitis-associated colorectal cancer.
Chartier LC; Howarth GS; Trinder D; Mashtoub S
Carcinogenesis; 2021 Feb; 42(2):202-209. PubMed ID: 32940671
[TBL] [Abstract][Full Text] [Related]
7. Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis.
Lindsay RJ; Geier MS; Yazbeck R; Butler RN; Howarth GS
Br J Nutr; 2010 Aug; 104(4):513-9. PubMed ID: 20377926
[TBL] [Abstract][Full Text] [Related]
8. [Diosmetin regulates intestinal immune balance by inhibiting PI3K/AKT signaling to relieve 2, 4, 6-trinitrobenzene sulfonic acid-induced Crohn's disease-like colitis in mice].
Yang Z; Zhao T; Cheng Y; Zhou Y; Li Y; Wang X; Zhang X; Zuo L; Ge S
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):474-482. PubMed ID: 37087594
[TBL] [Abstract][Full Text] [Related]
9. Emu Oil Combined with Lyprinol™ Reduces Small Intestinal Damage in a Rat Model of Chemotherapy-Induced Mucositis.
Mashtoub S; Lampton LS; Eden GL; Cheah KY; Lymn KA; Bajic JE; Howarth GS
Nutr Cancer; 2016 Oct; 68(7):1171-80. PubMed ID: 27618153
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
[TBL] [Abstract][Full Text] [Related]
11. Effects of polyphenolic maqui (
Ortiz-Cerda T; Argüelles-Arias F; Macías-García L; Vázquez-Román V; Tapia G; Xie K; García-García MD; Merinero M; García-Montes JM; Alcudia A; Witting PK; De-Miguel M
Front Immunol; 2023; 14():1229767. PubMed ID: 38283356
[TBL] [Abstract][Full Text] [Related]
12. Emu Oil Attenuates Disease Severity and Results in Fewer Large Colonic Tumors in a Mouse Model of Colitis-Associated Colorectal Cancer.
Mashtoub S; Chartier LC; Trinder D; Lawrance IC; Howarth GS
Nutr Cancer; 2022; 74(2):715-723. PubMed ID: 33840308
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
14. 1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis.
Santos FA; Silva RM; Campos AR; De Araújo RP; Lima Júnior RC; Rao VS
Food Chem Toxicol; 2004 Apr; 42(4):579-84. PubMed ID: 15019181
[TBL] [Abstract][Full Text] [Related]
15. [Pachymic acid protects against Crohn's disease-like intestinal barrier injury and colitis in miceby suppressingintestinal epithelial cell apoptosis
Shao R; Yang Z; Zhang W; Zhang N; Zhao Y; Zhang X; Zuo L; Ge S
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):935-942. PubMed ID: 37439165
[TBL] [Abstract][Full Text] [Related]
16. Emu Oil and zinc monoglycerolate independently reduce disease severity in a rat model of ulcerative colitis.
Mashtoub S; Howarth GS
Biometals; 2023 Dec; 36(6):1331-1345. PubMed ID: 37402926
[TBL] [Abstract][Full Text] [Related]
17. Emu oil offers protection in Crohn's disease model in rats.
Vemu B; Selvasubramanian S; Pandiyan V
BMC Complement Altern Med; 2016 Feb; 16():55. PubMed ID: 26852336
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of protein arginine deiminase-4 inhibitor in TNBS- induced colitis in mice.
Zhang T; Mei Y; Dong W; Wang J; Huang F; Wu J
Int Immunopharmacol; 2020 Jul; 84():106583. PubMed ID: 32416455
[TBL] [Abstract][Full Text] [Related]
19. Oenothera rosea L´Hér. ex Ait attenuates acute colonic inflammation in TNBS-induced colitis model in rats: in vivo and in silico myeloperoxidase role.
Calva-Candelaria N; Meléndez-Camargo ME; Montellano-Rosales H; Estrada-Pérez AR; Rosales-Hernández MC; Fragoso-Vázquez MJ; Martínez-Archundia M; Correa-Basurto J; Márquez-Flores YK
Biomed Pharmacother; 2018 Dec; 108():852-864. PubMed ID: 30372897
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.
Maines LW; Fitzpatrick LR; Green CL; Zhuang Y; Smith CD
Inflammopharmacology; 2010 Apr; 18(2):73-85. PubMed ID: 20151210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
